Topline data were announced from a phase 3 trial evaluating gefurulimab in adults with anti-acetylcholine receptor antibody-positive generalised myasthenia gravis.

John Williams, president of the Federal Reserve Bank of New York, discussed the outlook for the labor market, inflation and ...

As with the NMOSD-focused film, “Rare Connections in gMG” is aimed at countering the “relatively low” awareness of the rare disease, according to Christophe Hotermans, M.D., Ph.D., Alexion’s head of ...

New soliton solutions to the NLSE with parabolic nonlinearity are being explored, featuring conservation laws and pulse ...

It was around midnight – five days before Christmas 2022 – when Kenneth Lee, 59, arrived at the narrow parkette at the corner ...

Face forgery detection receives widespread attention due to the great security threats arising from the development of face forgery technologies. Most existing works define it as a binary ...

The US government’s new sanctions against Venezuela’s Cartel of the Suns incorrectly portray it as a hierarchical drug ...

Regeneron Pharmaceuticals delivered strong Q2 results and made net progress with its commercial portfolio and pipeline. Click ...

Results from the Phase III PREVAIL trial (NCT05556096) of gefurulimab demonstrated a statistically significant and clinically ...

Males born in summer months reported higher depression symptom scores than males born during other seasons, according to a ...

This case is sad and tragic in more ways than anyone can ever describe,” the defendant’s attorneys wrote in court documents.

Critics fear that personal data might be used to monitor immigrants and political foes, and to spread false tales of fraud.